Health Guard

Beijing Health Guard Biotechnology, registered in Beijing Economic and Technological Development Zone in 2008, is a high-tech enterprise focusing on the research, development, and production of innovative biopharmaceuticals in the field of public health. The company was officially listed on the National Equities Exchange and Quotations (NEEQ) system in September 2015, with the stock name: 3HG3, and stock code: 833575. Since its establishment, the company has centered its core technology and business direction on "the research and development of recombinant protein drugs based on structural design." Through continuous R&D practice, it has gradually established several leading domestic and international key technology platforms, including the design of recombinant virus-like particle (VLP) vaccines, VLP protein expression, vaccine engineering technology, quality evaluation of VLP vaccines, preparation and detection of vaccine antibodies, and has built a pilot base that meets GMP standards. Utilizing these elements, the company successfully developed a recombinant trivalent human papillomavirus (HPV) vaccine and a recombinant nonavalent HPV vaccine for the prevention of cervical cancer, and is currently developing a recombinant 15-valent HPV vaccine, a recombinant hand-foot-mouth disease (EV71/CoX A16 virus) vaccine, a recombinant norovirus (NoV) vaccine, and human parathyroid hormone (rh-PTH), among other preventive and therapeutic biological products. Over the past decade, the company has been recognized as a “Beijing Patent Engine Pilot Unit,” “Zhongguancun High-Tech Enterprise,” “Development Zone Enterprise Innovation Center,” “Beijing Science and Technology Development Research Institution,” “High-Tech Enterprise,” “New District Recombinant Virus-Like Particle Vaccine Preparation Public Technology Service Platform,” “Beijing Safety Culture Construction Demonstration Enterprise,” “Development Zone Overseas High-Level Talent Founded Enterprise,” 2018 Deloitte Yizhuang Rising Star, and 2019 Zhongguancun High-Precision Project, among others.